Asset Details
MbrlCatalogueTitleDetail
Do you wish to reserve the book?
Clinical Trial Data Science to Advance Precision Oncology
by
Plana, Deborah
in
Bioengineering
/ Bioinformatics
/ Biostatistics
/ Oncology
/ Pharmacology
2022
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
You are currently in the queue to collect this book. You will be notified once it is your turn to collect the book.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Oops! Something went wrong.
While trying to remove the title from your shelf something went wrong :( Kindly try again later!
Do you wish to request the book?
Clinical Trial Data Science to Advance Precision Oncology
by
Plana, Deborah
in
Bioengineering
/ Bioinformatics
/ Biostatistics
/ Oncology
/ Pharmacology
2022
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Dissertation
Clinical Trial Data Science to Advance Precision Oncology
2022
Request Book From Autostore
and Choose the Collection Method
Overview
Clinical trials are the most expensive and highest-stakes experiments in biomedicine, and their results determine which therapies are ultimately used to treat patients. While a typical pivotal trial costs millions of dollars and enrolls hundreds of patients, its associated data will not be made public, limiting our ability to learn from its results. We reconstructed otherwise siloed clinical trial data by using image analysis on published trial figures. We then developed methods to re-analyze these results at scale and help design more effective clinical and preclinical studies. In Chapter 1, we describe how a probabilistic model can predict the success of combination therapies in oncology using single agent data alone and how this insight can be leveraged to improve survival outcomes in presently incurable cancers. In Chapter 2, we find that a parametric distribution accurately describes the shape of survival curves in oncology trials, and we show how historical results can inform distribution parameters to more precisely infer drug efficacy from small sample sizes. We also find that differences in curve shape correspond to a violation of the proportional hazards assumption typically used to assess trial results and, consequently, that a trial’s length has an underappreciated impact on its likelihood of success. In Chapter 3, we develop a more powerful approach to detect patient subgroups responding to new therapies as compared to standard methods used in oncology basket trials. Finally, in Chapter 4, we apply the lessons learned from clinical data to incorporate interpatient heterogeneity into drug and biomarker discovery efforts using patient-derived mouse xenografts. This body of work offers new tools to better understand drug-response data in human, animal, and cell line studies. We hope that these methods help take clinical findings from the bedside back to the bench and advance precision oncology.
Publisher
ProQuest Dissertations & Theses
Subject
ISBN
9798819379684
MBRLCatalogueRelatedBooks
Related Items
Related Items
This website uses cookies to ensure you get the best experience on our website.